Risk factors for depression in Parkinson disease
E. Tandberg, J. P. Larsen, D. Aarsland, K. Laake and J. L. Cummings
Department of Neurology, Central Hospital of Rogaland, Stavanger, Norway.
OBJECTIVE: To evaluate whether depression in Parkinson disease (PD) is more
closely related to the underlying neuropathological process or to
environmental and psychological factors by correlating depression in PD
with various clinical and demographic variables. DESIGN: Major depression,
level of depressive symptoms as measured with the Montgomery-Aasberg
Depression Rating Scale (MADRS), and clinical characteristics were
investigated in a community-based cross-sectional study of carefully
diagnosed patients with PD. Both bivariate and multivariate correlation
analyses were performed to investigate correlations and predictive values
of possible risk factors for major depression and MADRS score in PD.
SETTING: Depression among patients with PD derived from a prevalence study
in the county of Rogaland, Norway. PATIENTS: Two hundred forty-five
patients with PD. RESULTS: Impaired cognitive function and the presence of
a thought disorder were significant predictors of major depression. A
Mini-Mental State Examination sum score below 24 and level 2 or higher on
the thought disorder subscale of the Unified Parkinson Disease Rating Scale
increased the probability of major depression by a factor of 6.6 and 3.5,
respectively. Higher MADRS scores were also associated with lower
Mini-Mental State Examination score and higher thought disorder score. In
addition, MADRS scores also correlated with more impairment in activities
of daily living, presence of motor fluctuations, more evidence of atypical
parkinsonism, higher daily doses of levodopa, and younger age on the day on
which prevalence was determined. CONCLUSIONS: Most of the observations of
this study favor the hypothesis that depression in PD is a primary
consequence of brain dysfunction. Situational factors may, however, also
contribute to mood changes in PD.
Depression and Stages of Huntington's Disease
Paulsen et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:496-502.
ABSTRACT
| FULL TEXT
Psychiatric Complications in Parkinson Disease
Weintraub and Stern
AJGP 2005;13:844-851.
ABSTRACT
| FULL TEXT
Prevalence and Treatment of Depression in Parkinson's Disease
Veazey et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:310-323.
ABSTRACT
| FULL TEXT
Distress in Parkinson's disease: contributions of disease factors and metacognitive style
ALLOTT et al.
Br. J. Psychiatry 2005;187:182-183.
ABSTRACT
| FULL TEXT
Depression is associated with impairment of ADL, not motor function in Parkinson disease
Holroyd et al.
Neurology 2005;64:2134-2135.
ABSTRACT
| FULL TEXT
Depression in Parkinson's Disease: Conceptual Issues and Clinical Challenges
Leentjens
J Geriatr Psychiatry Neurol 2004;17:120-126.
ABSTRACT
Psychiatric comorbidities in patients with Parkinson disease and psychosis
Marsh et al.
Neurology 2004;63:293-300.
ABSTRACT
| FULL TEXT
Sexuality in young patients with Parkinson's disease: a population based comparison with healthy controls
Jacobs et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:550-552.
ABSTRACT
| FULL TEXT
Reliance on external cues during serial sequential movement in major depression
Rogers et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:237-239.
ABSTRACT
| FULL TEXT
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon et al.
Brain 2000;123:733-745.
ABSTRACT
| FULL TEXT
Range of neuropsychiatric disturbances in patients with Parkinson's disease
Aarsland et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:492-496.
ABSTRACT
| FULL TEXT
Depression and Parkinson's Disease
JWatch Psychiatry 1997;1997:10-10.
FULL TEXT